ATC
NVAX icon

Adirondack Trust Company’s Novavax NVAX Stock Holding History

Adirondack Trust Company’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-231
Closed -$2.37K – 490
2022
Q4 		$2.37K Hold
231
– – ﹤0.01% 436
2022
Q3 		$4K Hold
231
– – ﹤0.01% 415
2022
Q2 		$12K Hold
231
– – 0.01% 296
2022
Q1 		$17K Hold
231
– – 0.01% 271
2021
Q4 		$33K Hold
231
– – 0.02% 209
2021
Q3 		$34K Hold
231
– – 0.02% 212
2021
Q2 		$49K Hold
231
– – 0.02% 189
2021
Q1 		$42K Hold
231
– – 0.02% 194
2020
Q4 		$51K Buy
+231
New +$24.6K 0.03% 171

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adirondack Trust Company's NVAX Position: Q1 2023 in Review

Adirondack Trust Company sold out of Novavax (NVAX) in Q1 2023, closing a stake of 231 shares — an estimated $2.37K sold.

Adirondack Trust Company first reported a position in NVAX in Q4 2020 and held it in 9 quarters. The position peaked at $51K in Q4 2020. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Adirondack Trust Company reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Adirondack Trust Company sold 231 Novavax shares in Q1 2023, an estimated $2.37K.
  • Adirondack Trust Company first reported a position in Novavax in Q4 2020 and held it in 9 quarters.
  • Adirondack Trust Company's Novavax position peaked at $51K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Adirondack Trust Company's 13F filing for Q1 2023, filed 28 Apr 2023.